|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM317845918 |
003 |
DE-627 |
005 |
20240923231841.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2020.108635
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1545.xml
|
035 |
|
|
|a (DE-627)NLM317845918
|
035 |
|
|
|a (NLM)33217544
|
035 |
|
|
|a (PII)S1521-6616(20)30795-6
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Yuki, Koichi
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Mechanistic consideration of the effect of perioperative volatile anesthetics on phagocytes
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 16.06.2021
|
500 |
|
|
|a Date Revised 23.09.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2020 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a A growing literature has shown that volatile anesthetics are promiscuous molecules targeting multiple molecules, some of which are critical for immunological functions. We focused on studies that delineated target molecules of volatile anesthetics on immune cells and summarized the effects of volatile anesthetics on immune functions. We also presented the perspectives of studying volatile anesthetics-mediated immunomodulation
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Immunomodulation
|
650 |
|
4 |
|a Surgery
|
650 |
|
4 |
|a Volatile anesthetics
|
650 |
|
7 |
|a Anesthetics, Inhalation
|2 NLM
|
650 |
|
7 |
|a Sevoflurane
|2 NLM
|
650 |
|
7 |
|a 38LVP0K73A
|2 NLM
|
650 |
|
7 |
|a Desflurane
|2 NLM
|
650 |
|
7 |
|a CRS35BZ94Q
|2 NLM
|
650 |
|
7 |
|a Isoflurane
|2 NLM
|
650 |
|
7 |
|a CYS9AKD70P
|2 NLM
|
700 |
1 |
|
|a Hou, Lifei
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shibamura-Fujiogi, Miho
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Koutsogiannaki, Sophia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Soriano, Sulpicio G
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 222(2021) vom: 04. Jan., Seite 108635
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:222
|g year:2021
|g day:04
|g month:01
|g pages:108635
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2020.108635
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 222
|j 2021
|b 04
|c 01
|h 108635
|